Aldosterone induces apoptosis in rat podocytes: Role of PI3-K/Akt and p38MAPK signaling pathways

Nephron - Experimental Nephrology

Volumn 113, Issue 1, 2009, Pages

  Chen, Cheng ^a,b   Liang, Wei ^a   Jia, Junya ^a   Van Goor, Harry ^b   Singhal, Pravin C ^c   Ding, Guohua ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

Aldosterone; Apoptosis; p38 mitogen activated protein kinase; Phosphatidylinositol 3 kinase Akt; Podocyte

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALDOSTERONE; BUFFER; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SPIRONOLACTONE; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL NUCLEUS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ALDOSTERONE; ANDROSTADIENES; ANIMALS; APOPTOSIS; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; IMIDAZOLES; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PODOCYTES; PYRIDINES; RATS; SPIRONOLACTONE;

EID: 67649850328     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000228080     Document Type: Article

References (39)

1. Espiner E, Nicholls M: The Renin Angiotensin System. London, Gower Medical Publishing, 2002, pp 1-33.
2. Brown NJ: Aldosterone and end-organ damage. Curr Opin Nephrol Hypertens 2005;14:235-241.
3. Miric G, Dallemagne C, Endre Z, et al: Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats. Br J Pharmacol 2001;133:687-694. (Pubitemid 32642874)
4. Rocha R, Chander PN, Zuckerman A, et al: Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats. Hypertension 1999;33:232-237. (Pubitemid 29065665)
5. Sun Y, Zhang J, Lu L, et al: Aldosterone-induced inflammation in the rat heart: role of oxidative stress. Am J Pathol 2002;161:1773-1781. (Pubitemid 35265535)
6. Furukawa T, Ohno S, Oguchi H, et al: Morphometric study of glomerular slit diaphragms fixed by rapid-freezing and freeze-substitution. Kidney Int 1991;40:621-624.
7. Aldigier JC, Kanjanbuch T, Ma LJ, et al: Regression of existing glomerulosclerosis by inhibition of aldosterone. J Am Soc Nephrol 2005;16:3306-3314. (Pubitemid 46187550)
8. Rocha R, Stier CT Jr, Kifor I, et al: Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology 2000;141:3871-3878. (Pubitemid 30815713)
9. Boldyreff B, Wehling M: Non-genomic actions of aldosterone: mechanisms and consequences in kidney cells. Nephrol Dial Transplant 2003;18:1693-1695. (Pubitemid 37098534)
10. Haseroth K, Gerdes D, Berger S, et al: Rapid nongenomic effects of aldosterone in mineralocorticoid-receptor-knockout mice. Biochem Biophys Res Commun 1999;266:257-261. (Pubitemid 30028801)
11. Kriz W, Gretz N, Lemley KV: Progression of glomerular diseases: is the podocyte the culprit? Kidney Int 1998;54:687-697.
12. Schiffer M, Bitzer M, Roberts IS, et al: Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 2001;108:807-816. (Pubitemid 32880291)
13. Ding G, Reddy K, Kapasi AA, et al: Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal Physiol 2002;283:F173-F180. (Pubitemid 34680484)
14. Wada T, Pippin JW, Marshall CB, et al: Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins. J Am Soc Nephrol 2005;16:2615-2625.
15. Susztak K, Raff AC, Schiffer M, et al: Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006;55:225-233. (Pubitemid 43343319)
16. Burniston JG, Saini A, Tan LB, et al: Aldosterone induces myocyte apoptosis in the heart and skeletal muscles of rats in vivo. J Mol Cell Cardiol 2005;39:395-399. (Pubitemid 40995029)
17. De Angelis N, Fiordaliso F, Latini R, et al: Appraisal of the role of angiotensin II and aldosterone in ventricular myocyte apoptosis in adult normotensive rat. J Mol Cell Cardiol 2002;34:1655-1665. (Pubitemid 35454480)
18. Ding G, van Goor H, Ricardo SD, et al: Oxidized LDL stimulates the expression of TGF-beta and fibronectin in human glomerular epithelial cells. Kidney Int 1997;51:147-154. (Pubitemid 27064532)
19. Lecoeur H, Prevost MC, Gougeon ML: Oncosis is associated with exposure of phosphatidylserine residues on the outside layer of the plasma membrane: a reconsideration of the specificity of the annexin V/propidium iodide assay. Cytometry 2001;44:65-72. (Pubitemid 32434004)
20. Ding G, Franki N, Kapasi AA, et al: Tubular cell senescence and expression of TGF-beta1 and p21(WAF1/CIP1) in tubulointerstitial fibrosis of aging rats. Exp Mol Pathol 2001;70:43-53. (Pubitemid 34412202)
21. Furukawa T, Ohno S, Oguchi H, et al: Morphometric study of glomerular slit diaphragms fixed by rapid-freezing and freeze-substitution. Kidney Int 1991;40:621-624.
22. Griendling KK, Harrison DG: Dual role of reactive oxygen species in vascular growth. Circ Res 1999;85:562-563. (Pubitemid 29431958)
23. Lodha S, Dani D, Mehta R, et al: Angiotensin II-induced mesangial cell apoptosis: role of oxidative stress. Mol Med 2002;8:830-840. (Pubitemid 36223136)
24. Blasi ER, Rocha R, Rudolph AE, et al: Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int 2003;63:1791-1800. (Pubitemid 36513325)
25. Nagase M, Shibata S, Yoshida S, et al: Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker. Hypertension 2006;47:1084-1093. (Pubitemid 44289165)
26. Nagase M, Fujita T: Aldosterone and glomerular podocyte injury. Clin Exp Nephrol 2008;12:233-242.
27. Lawlor MA, Alessi DR: PKB/Akt: a key mediator of cell proliferation, survival and insulin responses. J Cell Sci 2001;114:2903-2910.
28. Widmann C, Gibson S, Jarpe MB, et al: Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 1999;79:143-180. (Pubitemid 29056951)
29. Alvarado-Kristensson M, Porn-Ares MI, Grethe S, et al: p38 Mitogen-activated protein kinase and phosphatidylinositol 3-kinase activities have opposite effects on human neutrophil apoptosis. FASEB J 2002;16:129-131.
30. Foster RR, Saleem MA, Mathieson PW, et al: Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes. Am J Physiol Renal Physiol 2005;288:F48-F57.
31. Saldeen J, Lee JC, Welsh N: Role of p38 mitogen-activated protein kinase (p38 MAPK) in cytokine-induced rat islet cell apoptosis. Biochem Pharmacol 2001;61:1561-1569. (Pubitemid 32476910)
32. Cross DA, Alessi DR, Cohen P, et al: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995;378:785-789. (Pubitemid 26004411)
33. Carpenter CL, Duckworth BC, Auger KR, et al: Purification and characterization of phosphoinositide 3-kinase from rat liver. J Biol Chem 1990;265:19704-19711. (Pubitemid 120013919)
34. Mano A, Tatsumi T, Shiraishi J, et al: Aldosterone directly induces myocyte apoptosis through calcineurin-dependent pathways. Circulation 2004;110:317-323. (Pubitemid 38955501)
35. Lai XX, Ding GH, Huang CX, et al: Angiotensin II-induced podocyte apoptosis: role of the MAPK subtypes. Beijing Da Xue Xue Bao 2004;36:131-134.
36. Pitt B, Zannad F, Remme WJ, et al: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldosterone Evaluation Study Investigators. N Engl J Med 1999;341:709-717.
37. Pitt B, Leopold JA: A role for mineralocorticoid receptor blockade in the prevention of apoptosis. J Mol Cell Cardiol 2005;39:415-417. (Pubitemid 41133727)
38. Williams TA, Verhovez A, Milan A, et al: Protective effect of spironolactone on endothelial cell apoptosis. Endocrinology 2006;147:2496-2505.
39. Lee YS, Kim JA, Kim KL, et al: Aldosterone upregulates connective tissue growth factor gene expression via p38 MAPK pathway and mineralocorticoid receptor in ventricular myocytes. J Korean Med Sci 2004;19:805-811.